De-Intensified vs. Standard-Dose Proton Beam Therapy for Favorable Prognosis HPV-Mediated Oropharynx Cancer
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · e669
DOI: 10.1016/j.ijrobp.2026.06.2104 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von R. Dagan und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Dagan, R., Casper, A., Bryant, C., & Mendenhall, W. (2026). De-Intensified vs. Standard-Dose Proton Beam Therapy for Favorable Prognosis HPV-Mediated Oropharynx Cancer. International Journal of Radiation Oncology*Biology*Physics, 126(1), e669. https://doi.org/10.1016/j.ijrobp.2026.06.2104
Vancouver
Dagan R, Casper A, Bryant C, Mendenhall W. De-Intensified vs. Standard-Dose Proton Beam Therapy for Favorable Prognosis HPV-Mediated Oropharynx Cancer. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):e669. doi:10.1016/j.ijrobp.2026.06.2104
BibTeX
@article{Dagan2026,
author = {Dagan, R. and Casper, A.C. and Bryant, C.M. and Mendenhall, W.M.},
title = {De-Intensified vs. Standard-Dose Proton Beam Therapy for Favorable Prognosis HPV-Mediated Oropharynx Cancer},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {e669},
doi = {10.1016/j.ijrobp.2026.06.2104}
}
EUVIMED